I agree that this site is using cookies. You can find further informations here.
X
Lassman, A B
286  results:
Search for persons X
?
1

PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III ..:

Lassman, A B ; Polley, M C ; Iwamoto, F M...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii2-ii2 , 2023
Link: https://doi.org/10.1093/..
 
?
2

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain..:

Michaud, Laure ; Beattie, B. J. ; Akhurst, T....
European Journal of Nuclear Medicine and Molecular Imaging.  47 (2019)  6 - p. 1353-1367 , 2019
Link: https://doi.org/10.1007/..
 
?
3

PL3.5 Efficacy and safety of selinexor in recurrent gliobla..:

Lassman, A B ; Wen, P Y ; van den Bent, M...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii3-iii4 , 2019
Link: https://doi.org/10.1093/..
 
?
4

OS10.6 Infigratinib (BGJ398) in patients with recurrent gli..:

Lassman, A B ; Sepúlveda-Sánchez, J M ; Cloughesy, T...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii21-iii22 , 2019
Link: https://doi.org/10.1093/..
 
?
5

Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of ..:

Michaud, Laure ; Beattie, B. J. ; Akhurst, T....
European Journal of Nuclear Medicine and Molecular Imaging.  47 (2019)  1 - p. 4-4 , 2019
Link: https://doi.org/10.1007/..
 
?
6

P01.071Genomic profiling identifies tubulin mutations that ..:

Lassman, A B ; Roberts-Rapp, L ; He, L...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii246-iii246 , 2018
Link: https://doi.org/10.1093/..
 
?
7

OS07.5 Interim analysis data from Phase 2 study on efficacy..:

Lassman, A. B. ; Bent, M. J. V. D. ; Wen, P. Y....
Neuro-Oncology.  19 (2017)  suppl_3 - p. iii14-iii14 , 2017
Link: https://doi.org/10.1093/..
 
?
8

Multiparametric Subtraction Maps Guide Treatment Decisions ..:

Yanagihara, T.K. ; Grinband, J. ; Rowley, J....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E114 , 2016
Link: https://doi.org/10.1016/..
 
?
9

P08.19 Efficacy of a novel antibody-drug conjugate (ADC), A..:

van den Bent, M. ; Gan, H. K. ; Lassman, A. B....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv44-iv44 , 2016
Link: https://doi.org/10.1093/..
 
?
10

An Independently Validated Nomogram for Individualized Esti..:

Gittleman, H.R. ; Lim, D. ; Kattan, M....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. S92 , 2016
Link: https://doi.org/10.1016/..
 
?
11

P06.02 Transcriptional profiling to identify determinants a..:

van den Bent, M. ; Gan, H. ; Reardon, D. A....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv27-iv28 , 2016
Link: https://doi.org/10.1093/..
 
?
12

Adjuvant Stereotactic Radiosurgery to the Tumor Bed Improve..:

Yaeh, A. ; Nanda, T. ; Jani, A....
International Journal of Radiation Oncology*Biology*Physics.  93 (2015)  3 - p. E94-E95 , 2015
Link: https://doi.org/10.1016/..
 
?
13

2903 Identifying the correct patient (pt) population for AB..:

Van den Bent, M.J. ; Roberts-Rapp, L. ; Ansell, P....
European Journal of Cancer.  51 (2015)  - p. S585-S586 , 2015
Link: https://doi.org/10.1016/..
 
?
14

IDH-1 Mutation Status Predicts for Better Overall Survival ..:

Jani, A. ; Estrada, J. ; Gartrell, R....
International Journal of Radiation Oncology*Biology*Physics.  93 (2015)  3 - p. E75 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Changes in Diffusion Weighted Imaging Pre and Post Chemorad..:

Yanagihara, T. ; Chu, A. ; Garrett, M....
International Journal of Radiation Oncology*Biology*Physics.  93 (2015)  3 - p. E56-E57 , 2015
Link: https://doi.org/10.1016/..
 
1-15